GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » COGS-to-Revenue

Novonesis AS (Novonesis AS) COGS-to-Revenue : 0.46 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS COGS-to-Revenue?

Novonesis AS's Cost of Goods Sold for the three months ended in Dec. 2023 was $310 Mil. Its Revenue for the three months ended in Dec. 2023 was $673 Mil.

Novonesis AS's COGS to Revenue for the three months ended in Dec. 2023 was 0.46.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Novonesis AS's Gross Margin % for the three months ended in Dec. 2023 was 53.99%.


Novonesis AS COGS-to-Revenue Historical Data

The historical data trend for Novonesis AS's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS COGS-to-Revenue Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.45 0.44 0.42 0.45 0.46

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.46 0.45 0.46 0.46

Novonesis AS COGS-to-Revenue Calculation

Novonesis AS's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1196.378 / 2618.804
=0.46

Novonesis AS's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=309.885 / 673.465
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novonesis AS  (OTCPK:NVZMY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Novonesis AS's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 309.885 / 673.465
=53.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Novonesis AS COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Novonesis AS's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (Novonesis AS) Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

Not Just Yogurt Anymore

By PRNewswire 10-26-2023

Novozymes A/S's Dividend Analysis

By GuruFocus Research 10-19-2023

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso 11-06-2019